New BSP study publication: Heparin Low-Molecular-Mass for Assay BRP

EDQM 09/05/2022 Strasbourg, France

An article on the outcome of the Biological Standardisation Programme (BSP) study for the establishment of the European Pharmacopoeia (Ph. Eur.) Heparin Low-Molecular-Mass for Assay Biological Reference Preparation batch 11 is now available online. The article has been published in Pharmeuropa...

Read More

New Pharmeuropa Bio & Scientific Notes article now online: Human immunoglobulin for ACA BRP

EDQM 13/04/2022 Strasbourg, France

A new scientific article on the outcome of a recently concluded Biological Standardisation Programme (BSP) study has been published in Pharmeuropa Bio & Scientific Notes 2022. Four replacement batches of the European Pharmacopoeia (Ph. Eur.) Biological Reference Preparation (BRP) for Human...

Read More

Proceedings of Workshop on alternatives to animal testing in Quality Control of Veterinary Vaccines now available

EDQM 12/04/2022 Strasbourg, France

The proceedings of the workshop "Novel in-vitro model as alternative to in vivo toxoid vaccines testing: Clostridium septicum vaccine as proof of concept" have been published in FreePub, a free online EDQM journal. The event, held in March 2021, was jointly organised by the European Directorate...

Read More

EDQM Laboratory’s ISO 17025:2017 accreditation renewed

EDQM 15/11/2021 Strasbourg, France

The European Directorate for the Quality of Medicines & HealthCare (EDQM) Laboratory successfully obtained the renewal of its accreditation according to the ISO/IEC 17025:2017 standard in October 2021 from the Belgian accreditation organisation BELAC, confirming the validity of the results...

Read More

New publication on an EDQM Biological Standardisation Programme study for standardisation of allergen products

EDQM 03/08/2021 Strasbourg, France

Following the successful completion of the BSP090 study on recombinant major allergens, in collaboration with project leaders from the Paul-Ehrlich-Institut, an article on one of the major study outcomes “Validation of a candidate European Pharmacopoeia standard method for quantification of major...

Read More

Highlights of 2020 – EDQM annual report now available

EDQM 06/07/2021 Strasbourg, France

The 2020 annual report of the European Directorate for the Quality of Medicines & HealthCare (EDQM) is now available, providing a comprehensive overview of its activities, achievements and events. While the year 2020 will long be remembered for the COVID-19 pandemic almost bringing the world to a...

Read More

Clostridium septicum vaccine antigen assays: new article available online in Pharmeuropa Bio & Scientific Notes

EDQM 29/06/2021 Strasbourg, France

The outcome of Part 2 of the BSP130 collaborative study run under the common aegis of the European Partnership for Alternative Approaches to Animal Testing (EPAA) and the European Directorate for the Quality of Medicines & HealthCare (EDQM) Biological Standardisation Programme (BSP) has just been...

Read More

New Pharmeuropa Bio & Scientific Notes article: Factor VIII BRP

EDQM 11/06/2021 Strasbourg, France

An article on the successful outcome of a recent study of the Biological Standardisation Programme (BSP) of the European Directorate for the Quality of Medicines & HealthCare (EDQM) has been published in Pharmeuropa Bio & Scientific Notes, the EDQM’s free online journal. The study for the...

Read More

New Pharmeuropa Bio & Scientific Notes article: Pertussis Toxin BRP batch 2

EDQM 18/05/2021 Strasbourg, France

A new article on the successful outcome of the study for the establishment of European Pharmacopoeia Pertussis Toxin Biological Reference Preparation (BRP) batch 2 has been published in Pharmeuropa Bio & Scientific Notes.

Read More

Phasing out animal testing for in-process control of veterinary vaccines: Clostridium septicum as a proof of concept

EDQM 24/03/2021 Strasbourg, France

On 9 and 10 March 2021, a workshop aimed at facilitating the implementation of replacement in vitro toxicity and antigenicity assays for Clostridium septicum vaccine antigens was jointly organised by the European Directorate for the Quality of Medicines & HealthCare (EDQM/Council of Europe), the...

Read More

Ph. Eur. Commission adopts revised monograph on Erythropoietin concentrated solution (1316)

EDQM 08/09/2020 Strasbourg, France

The approach to the elaboration of European Pharmacopoeia (Ph. Eur.) monographs for biotherapeutics has significantly evolved in recent years. In particular, where monographs on complex biotherapeutics are concerned, the emphasis is now placed on allowing greater flexibility as a means of better...

Read More

Pertussis Toxin BRP batch 2 available soon

EDQM 14/08/2020 Strasbourg, France

The Ph. Eur. Commission adopted the replacement batch (batch 2) of the Pertussis Toxin Biological Reference Preparation by correspondence in May 2020. Batch 1 is currently available for regular sales. Batch 2 will be available from the EDQM once the remaining stocks of batch 1 have been...

Read More

“EDQM Highlights – 2019 annual report” published

EDQM 30/06/2020 Strasbourg, France

The European Directorate for the Quality of Medicines & HealthCare’s 2019 annual report is now available, providing a comprehensive overview of our activities in 2019 and information on our achievements and events. We support health systems at national level and help protect patients by enabling...

Read More

EDQM website search engine deactivated

EDQM 02/03/2020 Strasbourg, France

The EDQM regrets to inform its users that the search engine on its website has been deactivated and is currently unavailable for technical reasons. We are aware of this recurring issue and are working on a long-term solution. We therefore request that our users refrain from contacting the EDQM...

Read More

Ph. Eur. to replace Histamine Sensitisation Test (HIST) for residual pertussis toxin testing

EDQM 14/01/2019 Strasbourg, France

The European Pharmacopoeia (Ph. Eur.) Commission has decided to replace the Histamine Sensitisation Test “HIST” (test in mice) with a standardised CHO cell clustering assay (in vitro cell-based test) for residual pertussis toxin testing in acellular pertussis vaccines, as of next year. The...

Read More

EDQM welcomes WHO recommendation to discontinue innocuity test in guidelines on vaccines and biologicals

EDQM 06/12/2018 Strasbourg, France

The EDQM has welcomed the recommendation of the WHO Expert Committee on Biological Standardization (ECBS) to omit the abnormal toxicity test (also called the innocuity test) in all future WHO documents on vaccines and other biological products, and to disregard the inclusion of this test in...

Read More